NCT00919893View on ClinicalTrials.gov

Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS)

PHASE3CompletedINTERVENTIONAL

Enrollment

139

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions

Chronic ProstatitisChronic Pelvic Pain Syndrome

Interventions

DRUG

Cernilton

Oral Cernilton, 2 capsules every 8 hours with the active substance consisting of 23 mg Extractum Pollens siccatum, 4 mg L-glutamate and 0.23 mg Stigmasterol per capsule for 12 weeks.

DRUG

Placebo

Oral placebo, 2 capsules every 8 hours with identical capsulation and weight only containing the inactive substances in proportional doses as compared with Cernilton for 12 weeks.

Trial Locations (1)

D-35392

Justus-Liebig-University, Giessen

All Listed Sponsors

collaborator

Strathmann AG&Co, Hamburg, Germany

UNKNOWN

collaborator

Cernelle, Ängelholm, Sweden

UNKNOWN

lead

University of Giessen

OTHER

NCT00919893 - Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS) | Biotech Hunter | Biotech Hunter